Tariff threats from the US are colliding with India’s export surge, and that clash is putting a fresh spotlight on large-cap ...

The FTSE Emerging Markets All Cap Index review includes additions, exclusions and weight changes across Indian equities. The ...

Biocon founder Kiran Mazumdar-Shaw recently criticized luxury brand Fendi over its Rs 8.3 lakh Navratri-style bag, stating it ...

Fifteen startups and four student teams were announced as the winners of the 9th edition of C-CAMP’s National Bio Entrepreneurship Competition (NBEC) 2026, held today in the presence of Dr […] ...

Indian biopharma firm Biocon has announced the signing of partnership agreement with Bahiafarma and Bionovis for Pertuzumab ...

On 8, Biocon Limited (“Biocon”) announced that, in partnership with Bahiafarma, a Brazilian public pharmaceutical laboratory, and ...

Biocon Limited confirms remittance of final dividend for FY 2025-26. Details on dividend amount, payment method, and shareholder verification with RTA KFin Technologies.

Biocon, Raymond, and Innovision are in focus today. Check updates on Biocon's potential block deal, Raymond's capital raise, ...

Lupin Limited has received marketing approval for its biosimilar pegfilgrastim in India, aiding in chemotherapy recovery. The ...

Coforge, Biocon, Shadowfax and Rays of Belief make headlines, while Enviro Infra Engineers bags a Rs 189.99 crore wind power ...

Biocon has secured a 10-year route into Brazil’s public pertuzumab market through a Productive Development Partnership ...

Biocon secures a 10-year Brazil supply deal for Pertuzumab, gaining exclusive access to 70% of the public market. Learn about the deal structure and risks.